3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection

Documenti analoghi

• Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice
  di: Siyu Tian, et al.
  Pubblicazione: (2021-10-01)
• A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
  di: Haisheng Yu, et al.
  Pubblicazione: (2023-09-01)
• The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
  di: Chen, X, et al.
  Pubblicazione: (2024)
• The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine.
  di: Xiaorui Chen, et al.
  Pubblicazione: (2024-06-01)
• RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
  di: Qingtai Liang, et al.
  Pubblicazione: (2022-04-01)